Verastem (VSTM) Capital Expenditures (2011 - 2024)

Verastem's (VSTM) quarterly Capital Expenditures came in at $21000.0 in Q2 2024, up 200.0% quarter-over-quarter from $7000.0 in Q1 2024.

Verastem (VSTM) Capital Expenditures (2011 - 2024) Analysis & Trends

Verastem's Capital Expenditures history runs 9 years deep, the most recent figure standing at $21000.0 for Q2 2024.

  • On a quarterly basis, Capital Expenditures changed N/A year-over-year to $21000.0 in Q2 2024; TTM through Dec 2024 was $28000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $28000.0, up 300.0% from the prior year.
  • Capital Expenditures grew to $21000.0 in Q2 2024 per VSTM's latest filing, from $7000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $196000.0 in Q1 2021 and bottomed at -$7000.0 in Q2 2020.
  • The 3-year median for Capital Expenditures is $17000.0 (2020), against an average of $42833.3.
  • Biggest YoY gain for Capital Expenditures was 1407.69% in 2021; the steepest drop was 1407.69% in 2021.
  • Year by year, Capital Expenditures stood at $27000.0 in 2020, then jumped by 625.93% to $196000.0 in 2021, then plunged by 89.29% to $21000.0 in 2024.
  • Per Business Quant, the three latest VSTM Capital Expenditures figures stand at $21000.0 (Q2 2024), $7000.0 (Q1 2024), and $196000.0 (Q1 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -8,939.03
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 43.25 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 133.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 230.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 786,000.00
10 Verastem 166.09 Mn -31.73 Mn 15.90 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2024 21,000.00
Jun 30, 2024 21,000.00
Mar 31, 2024 7,000.00
Mar 31, 2024 7,000.00
Mar 31, 2021 196,000.00
Mar 31, 2021 196,000.00
Sep 30, 2020 27,000.00
Sep 30, 2020 27,000.00
Jun 30, 2020 -7,000.00
Jun 30, 2020 -7,000.00
Mar 31, 2020 13,000.00
Mar 31, 2020 13,000.00
Dec 31, 2018 263,000.00
Dec 31, 2018 263,000.00
Sep 30, 2018 567,000.00
Sep 30, 2018 567,000.00
Jun 30, 2018 575,000.00
Jun 30, 2018 575,000.00
Mar 31, 2018 102,000.00
Mar 31, 2018 102,000.00